5-56911234-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153706.4(SETD9):c.164C>T(p.Thr55Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000879 in 1,603,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153706.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SETD9 | NM_153706.4 | c.164C>T | p.Thr55Ile | missense_variant | 2/6 | ENST00000285947.5 | NP_714917.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SETD9 | ENST00000285947.5 | c.164C>T | p.Thr55Ile | missense_variant | 2/6 | 1 | NM_153706.4 | ENSP00000285947 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000112 AC: 27AN: 241254Hom.: 0 AF XY: 0.0000997 AC XY: 13AN XY: 130404
GnomAD4 exome AF: 0.0000923 AC: 134AN: 1451024Hom.: 0 Cov.: 29 AF XY: 0.0000790 AC XY: 57AN XY: 721474
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.164C>T (p.T55I) alteration is located in exon 2 (coding exon 2) of the SETD9 gene. This alteration results from a C to T substitution at nucleotide position 164, causing the threonine (T) at amino acid position 55 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at